MLSS: Milestone Scientific Inc Long-Term Debt Volume

Graphic logo of Milestone Scientific Corporation (MLSS)

Milestone Scientific (MLSS) develops high-precision drug delivery systems, utilizing a patented pressure-adjustment method in The Wand device for comfortable dental anesthesia. The stock price trend confirms the current metric at 0.00. Demand for such innovations is moderately dependent on economic cycles, maintaining resilience due to the essential nature of healthcare. Management aims to optimize sales, anticipating faster adoption of new technologies by clinics.

MLSS Milestone Scientific: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Milestone Scientific

- price and consensus price forecast:
Share Price milestonescientific.com|MLSS - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Milestone Scientific|MLSS - Enterprise Value
- book capitalization data:
Accounting Value per Share Milestone Scientific|MLSS - Book Capitalization|Market Capitalization to Book Value Ratio milestonescientific.com|MLSS - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Milestone Scientific|MLSS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Milestone Scientific Corporation|MLSS - Company Aggregate Debts|Debts to Net Assets Milestone Scientific|MLSS - Company Long-Term Debt|Company Short-Term Indebtedness Milestone Scientific
General company analysis:milestonescientific.com (MLSS)
Mass-produced product of Milestone Scientific Corporation

Long-term debt measures the total liabilities with a maturity of more than one year, allowing for an assessment of management's ability to balance financial stability with investment growth. An analysis of the long-term liabilities of Milestone Scientific (MLSS) helps investors determine if the company has sufficient capital to fund scientist salaries and the development of robotic lines while maintaining protection against external economic shocks.

Competitor analysis

Company Long-Term Indebtedness intuitive.com ISRG|Company Long-Term Debts DHR (Danaher)|BDX - Long-Term Debt Volume|STE (STERIS Corporation) - Company Long-Term Debts|West Pharma Corp (WST) - Company Long-Term Liabilities|BAX (Baxter International) - Company Long-Term Debts|Company Long-Term Debts MASI|Company Long-Term Debt Stevanato Group (STVN)|Company Long-Term Debt Teleflex Inc. TFX|Company Long-Term Liabilities Merit Medical Systems Inc|Company Long-Term Loans and Borrowings Nobel Biocare NVST|Company Long-Term Debts ICUI (ICU Medical, Inc.)|XRAY: Long-Term Debt Volume|Company Long-Term Debt LeMaitre Vascular|ATRC (AtriCure Inc) - Company Long-Term Indebtedness|STAA: Company Long-Term Debt|Long-Term Debt Volume niagenbioscience.com (NAGE)|Company Long-Term Liabilities ZimVie Inc.|Amount of Long-Term Liabilities ANGO (angiodynamics.com)|Company Long-Term Debt Cerus|TKNO - Company Long-Term Loans and Borrowings|Monogram Technologies Inc - Company Long-Term Liabilities|STSS: Company Long-Term Debts|INFU (infusystem.com) - Company Long-Term Debt|utahmed.com (UTMD) - Company Long-Term Liabilities|Company Long-Term Debts KRMD (KORU Medical Systems, Inc.)|Long-Term Debt NYXH|Company Long-Term Debt Microbot Medical Inc MBOT|Company Long-Term Indebtedness Pro-Dex Inc. PDEX|Company Long-Term Liabilities Zentek Ltd. (ZTEK)|elutia.com - Amount of Long-Term Liabilities|Company Long-Term Debt NXGL (NEXGEL)|RVP: Long-Term Debt Volume|HBIO (Harvard Bioscience, Inc.) - Company Long-Term Debt|Femasys Corporation (FEMY) - Company Long-Term Liabilities|MHUA: Company Long-Term Debts|Long-Term Debt Volume POAI|Company Long-Term Debt Callan JMB Inc (CJMB)|Company Long-Term Debt Atrion Corp. (ATRI)|NURO: Company Long-Term Debts